Status:
RECRUITING
Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES
Lead Sponsor:
University of Pittsburgh
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
CARES
Standard of Care
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The trial will examine the effectiveness and facilitators and barriers of implementation of CARES, an integrated screening and stepped collaborative care intervention
Detailed Description
Over 18 million Americans are living with cancer. Half of them report clinically significant levels of depression, pain, and/or fatigue. According to the NIH consensus statement, these are the three m...
Eligibility Criteria
Inclusion
- Diagnosis of Cancer
- Age 18 years or older
- Read and write in English
Exclusion
- Evidence of thought disorder
- Evidence of delusions
- Evidence of hallucinations
- Evidence of suicidal ideation with a plan
Key Trial Info
Start Date :
August 8 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2030
Estimated Enrollment :
1750 Patients enrolled
Trial Details
Trial ID
NCT07183527
Start Date
August 8 2025
End Date
January 31 2030
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh Medical Center (UPMC) Cancer Center
Pittsburgh, Pennsylvania, United States, 15213